Stay updated on Oral PHA-022121 Dose-ranging Clinical Trial
Sign up to get notified when there's something new on the Oral PHA-022121 Dose-ranging Clinical Trial page.

Latest updates to the Oral PHA-022121 Dose-ranging Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedThe page's revision history now includes a new entry for Revision v3.3.2. The entry for Revision v3.2.0 has been removed.SummaryDifference0.1%

- Check28 days agoChange DetectedThe government funding/operating status notice displayed on the page has been removed.SummaryDifference0.5%

- Check42 days agoChange DetectedA new version entry appears in the Record History and minor UI adjustments are visible; core study content remains unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check71 days agoChange DetectedAdded a prominent operating-status notice and a new software version (v3.2.0); removed the old version label (v3.1.0).SummaryDifference10%

- Check78 days agoChange DetectedVersion bump from v3.0.2 to v3.1.0. This signals a software update; no other content changes are indicated.SummaryDifference0.2%

- Check93 days agoChange DetectedVersion label updated from v3.0.1 to v3.0.2 and the Back to Top element was removed; these are minor UI/metadata changes with no impact on core content.SummaryDifference0.6%

Stay in the know with updates to Oral PHA-022121 Dose-ranging Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Oral PHA-022121 Dose-ranging Clinical Trial page.